Search Orphan Drug Designations and Approvals
-
| Generic Name: | sterile, processed, homogenized amniotic fluid solution |
|---|---|
| Date Designated: | 09/12/2025 |
| Orphan Designation: | treatment of epidermolysis bullosa |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Eliksa Therapeutics, Inc. Pennsylvania Biotechnology Center 3805 Old Easton Rd Doylestown, Pennsylvania 18902 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







